Also categorized in BoardMoves:
Target CEO Gregg Steinhafel Resigns In Data Breach Fallout
x hide permanently

Valeant Pharmaceuticals Announces The Addition Of Sarah B. Kavanagh To Its Board Of Directors

Stock Market

 Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) today announced that the Board of Directors has appointed Ms. Sarah B. Kavanagh to serve as a director of the Board, effective July 22, 2016. With these changes, Valeant has increased the size of its board to 12 members, 11 of whom are independent ...

Mentions: Investment Independent Director Governance Committee